🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study designed to ascertain the effect of PF-04447943 on QT inter...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-06-29
Trial ID
NCT02785770
Treatments Being Tested
Evaluate the safety and tolerability of PF-04447943 after administration of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00832052
Treatments Being Tested
To describe the safety, tolerability and pharmacokinetics of PF-04447943 af...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2008-08
Trial ID
NCT00736528
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of PF-...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01097876
Treatments Being Tested
The purpose of this study is to evaluate the effects of PF-04447943 compare...
Status
Completed
Location
Neurology Clinic, PC
Start Date
2009-09-10
Trial ID
NCT00930059
Treatments Being Tested
This study is being conducted to assess the safety, tolerability, pharmacok...
Status
Completed
Location
University of Illinois Hospital and Health Sciences System
Start Date
2014-12
Trial ID
NCT02114203
Treatments Being Tested
The purpose of the study is to evaluate the safety of PF-04447943 when give...
Status
Completed
Location
Glendale Adventist Medical Center
Start Date
2009-10-26
Trial ID
NCT00988598
Treatments Being Tested
The purpose of the study is to compare the plasma drug levels of PF-0444794...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00886093
Treatments Being Tested
This study is designed to investigate the safety, tolerability, and pharmac...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-08
Trial ID
NCT00959803
Treatments Being Tested